NO20025461L - Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron - Google Patents
Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitronInfo
- Publication number
- NO20025461L NO20025461L NO20025461A NO20025461A NO20025461L NO 20025461 L NO20025461 L NO 20025461L NO 20025461 A NO20025461 A NO 20025461A NO 20025461 A NO20025461 A NO 20025461A NO 20025461 L NO20025461 L NO 20025461L
- Authority
- NO
- Norway
- Prior art keywords
- disulfophenyl
- butylnitron
- tert
- alpha
- new formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001916A SE0001916D0 (sv) | 2000-05-23 | 2000-05-23 | Novel formulation |
PCT/SE2001/001164 WO2001089507A1 (en) | 2000-05-23 | 2001-05-22 | NOVEL FORMULATIONS OF α-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025461L true NO20025461L (no) | 2002-11-14 |
NO20025461D0 NO20025461D0 (no) | 2002-11-14 |
Family
ID=20279797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025461A NO20025461D0 (no) | 2000-05-23 | 2002-11-14 | Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron |
Country Status (30)
Country | Link |
---|---|
US (2) | US20030181527A1 (de) |
EP (1) | EP1294369B1 (de) |
JP (1) | JP3744857B2 (de) |
KR (1) | KR20030001545A (de) |
CN (1) | CN1268326C (de) |
AR (1) | AR030218A1 (de) |
AT (1) | ATE303803T1 (de) |
AU (2) | AU6093501A (de) |
BR (1) | BR0111055A (de) |
CA (1) | CA2408781A1 (de) |
CZ (1) | CZ20023849A3 (de) |
DE (1) | DE60113255T2 (de) |
DK (1) | DK1294369T3 (de) |
EE (1) | EE200200653A (de) |
ES (1) | ES2247112T3 (de) |
HK (1) | HK1051649A1 (de) |
HU (1) | HUP0302310A3 (de) |
IL (1) | IL152533A0 (de) |
IS (1) | IS6610A (de) |
MX (1) | MXPA02011533A (de) |
MY (1) | MY130445A (de) |
NO (1) | NO20025461D0 (de) |
NZ (1) | NZ522329A (de) |
PL (1) | PL361284A1 (de) |
RU (1) | RU2271800C2 (de) |
SE (1) | SE0001916D0 (de) |
SK (1) | SK16542002A3 (de) |
TW (1) | TWI259078B (de) |
WO (1) | WO2001089507A1 (de) |
ZA (1) | ZA200208747B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050182060A1 (en) * | 2004-02-13 | 2005-08-18 | Kelly Michael G. | 2-Substituted and 4-substituted aryl nitrone compounds |
US9265834B2 (en) | 2009-03-05 | 2016-02-23 | Ablynx N.V. | Stable formulations of polypeptides and uses thereof |
EP2403873A1 (de) | 2009-03-05 | 2012-01-11 | Ablynx N.V. | Neue antigenbindende dimerkomplexe, verfahren zur herstellung/vermeidung und anwendungen davon |
AU2010289838C1 (en) | 2009-08-24 | 2014-03-06 | Hough Ear Institute | Methods for treating acute acoustic trauma |
EP2805731B1 (de) * | 2009-09-03 | 2018-10-31 | Ablynx N.V. | Stabile Formulierungen aus Polypeptiden und Verwendungen davon |
EP2512489A4 (de) * | 2009-12-15 | 2014-04-02 | Merck Sharp & Dohme | Formulierungen aus acadesin |
AU2012211989B2 (en) * | 2011-02-04 | 2017-03-02 | Hough Ear Institute | Methods for treating brain injury |
WO2014064717A1 (en) * | 2012-10-25 | 2014-05-01 | Fresenius Kabi Oncology Limited | Stable pharmaceutical composition of 5-αζα-2'ρεοχυοτιρινε |
US10660851B2 (en) | 2015-01-02 | 2020-05-26 | Rxos Medical | Polyfunctional radical scavenger hydrogel formulation |
CN116650411A (zh) * | 2022-02-25 | 2023-08-29 | 广州喜鹊医药有限公司 | 一种注射用硝酮嗪药物组合物及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE110565T1 (de) * | 1989-10-17 | 1994-09-15 | Oklahoma Med Res Found | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. |
JP2813023B2 (ja) * | 1990-03-13 | 1998-10-22 | 株式会社神戸製鋼所 | Mis型ダイヤモンド電界効果トランジスタ |
US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
-
2000
- 2000-05-23 SE SE0001916A patent/SE0001916D0/xx unknown
-
2001
- 2001-05-09 AR ARP010102188A patent/AR030218A1/es not_active Application Discontinuation
- 2001-05-10 TW TW090111180A patent/TWI259078B/zh not_active IP Right Cessation
- 2001-05-21 MY MYPI20012391A patent/MY130445A/en unknown
- 2001-05-22 SK SK1654-2002A patent/SK16542002A3/sk unknown
- 2001-05-22 BR BR0111055-1A patent/BR0111055A/pt not_active IP Right Cessation
- 2001-05-22 MX MXPA02011533A patent/MXPA02011533A/es active IP Right Grant
- 2001-05-22 JP JP2001585752A patent/JP3744857B2/ja not_active Expired - Fee Related
- 2001-05-22 WO PCT/SE2001/001164 patent/WO2001089507A1/en active IP Right Grant
- 2001-05-22 HU HU0302310A patent/HUP0302310A3/hu unknown
- 2001-05-22 RU RU2002129588/15A patent/RU2271800C2/ru not_active IP Right Cessation
- 2001-05-22 DK DK01934785T patent/DK1294369T3/da active
- 2001-05-22 ES ES01934785T patent/ES2247112T3/es not_active Expired - Lifetime
- 2001-05-22 IL IL15253301A patent/IL152533A0/xx unknown
- 2001-05-22 AU AU6093501A patent/AU6093501A/xx active Pending
- 2001-05-22 EE EEP200200653A patent/EE200200653A/xx unknown
- 2001-05-22 PL PL36128401A patent/PL361284A1/xx not_active Application Discontinuation
- 2001-05-22 EP EP01934785A patent/EP1294369B1/de not_active Expired - Lifetime
- 2001-05-22 AU AU2001260935A patent/AU2001260935B2/en not_active Ceased
- 2001-05-22 AT AT01934785T patent/ATE303803T1/de not_active IP Right Cessation
- 2001-05-22 CN CNB018098401A patent/CN1268326C/zh not_active Expired - Fee Related
- 2001-05-22 DE DE60113255T patent/DE60113255T2/de not_active Expired - Fee Related
- 2001-05-22 CA CA002408781A patent/CA2408781A1/en not_active Abandoned
- 2001-05-22 CZ CZ20023849A patent/CZ20023849A3/cs unknown
- 2001-05-22 US US10/276,747 patent/US20030181527A1/en not_active Abandoned
- 2001-05-22 KR KR1020027015761A patent/KR20030001545A/ko active IP Right Grant
- 2001-05-22 NZ NZ522329A patent/NZ522329A/en unknown
-
2002
- 2002-10-29 ZA ZA200208747A patent/ZA200208747B/en unknown
- 2002-11-11 IS IS6610A patent/IS6610A/is unknown
- 2002-11-14 NO NO20025461A patent/NO20025461D0/no unknown
-
2003
- 2003-05-30 HK HK03103875A patent/HK1051649A1/xx not_active IP Right Cessation
-
2007
- 2007-10-12 US US11/974,504 patent/US20080161406A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
HRP20050439B1 (en) | New use of dextran sulfate | |
ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
SE0100901D0 (sv) | New composition | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
NO20034863D0 (no) | Deuterert 3-piperidinopropiofenon og medikamenter inneholdende disse | |
DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
NO20025461L (no) | Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron | |
ZA200208761B (en) | Pharmaceutical form of administration for peptides, methods for its production and use. | |
ATE325135T1 (de) | 2-alkylierte cyclodextrinderivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung | |
ES2422081T3 (es) | Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales | |
ATE389655T1 (de) | Pyrimidinderivate | |
ITMI992107A0 (it) | Uso del baclofen nel trattamento dell'astinenza da etanolo | |
EA200300110A1 (ru) | Композиция элетриптана в виде частиц | |
BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
CY1108053T1 (el) | Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου | |
BR0210632A (pt) | Tratamento de doença parasìtica | |
BR0314139A (pt) | Derivados de 1,4-pirazina substituìdos | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
YU87501A (sh) | Farmaceutski kompleksi | |
RS51316B (sr) | Nova upotreba (r)-(-)-2-/5-(4-fluorofenil)-3- piridilmetilaminometil/-hromana i njegovih fiziološki prihvatljivih soli | |
AR023452A1 (es) | Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor | |
EA200401454A1 (ru) | Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний | |
ECSP045210A (es) | 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco |